Infectious diseases Archives - Page 14 of 34

Infectious diseases

Clinical Articles

Vaccines build on herd immunity

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Expert/s: Rosalyn Page

Infectious diseases

Clinical Articles

Preparing for the next COVID wave

GPs should plan antivirals for high- risk patients

Expert/s: Ben Falkenmire

Infectious diseases

Clinical Articles

Here’s another type of COVID test to get your head around. But is this new home kit worth the cost?

A new type of COVID test is set to be available from November for Australians to use at home.

Expert/s: Healthed

Infectious diseases

Podcasts

Practical guide to using COVID antivirals in primary care

Navigating interactions... it’s easier than it first looks, and how antivirals are an important part of the management strategy to reduce the chances of severe illness and hospital admissions

Expert/s: Dr Alexander Padiglione

Infectious diseases

Clinical Articles

The best COVID antivirals to prescribe

Under national guidelines, patients with COVID at high risk of serious illness should be prescribed nirmatrelvir (Paxlovid) by GPs, with the less effective molnupiravir (Lagevrio) a second-line option.

Expert/s: Ben Falkenmire

Infectious diseases

Podcasts

COVID Update, Vaccines, and Re-emerging Infections

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?

Expert/s: Prof Nigel Crawford

Infectious diseases

Clinical Articles

Campaign to encourage complacent Australians to get boosted

The Immunisation Coalition has launched a campaign called 'Take It From Me' to encourage Australians to get boosted.

Expert/s: Healthed

Infectious diseases

Clinical Articles

Alarming time for infectious diseases

Vigilance is required now international travel is back, says Associate Professor Sanjaya Senanayake.

Expert/s: Ben Falkenmire

Infectious diseases

Podcasts

COVID Update, Monkeypox and other outbreaks to keep an eye on

Monkeypox, influenza, polio, tomato flu and other things that are keeping public health up at night, latest COVID developments, ATAGI announcements.

Expert/s: A/Prof Sanjaya Senanayake

Infectious diseases

Clinical Articles

Australia needs a CDC: Nigel Crawford

It’s time to emerge from the ‘bubble of COVID’ and check out what other countries are doing to keep track of vaccination rates and impacts, says paediatrician Associate Professor Nigel Crawford.

Expert/s: Leigh Dayton

Infectious diseases

Podcasts

Shingles vaccination in the immunocompromised – Which option for which patient?

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Expert/s: Prof Tony Cunningham AO

Dermatology, Infectious diseases

Clinical Articles

What counts as ‘immunocompromised’ for Zostavax?

When deciding whether to administer Zostavax or not, it’s useful to keep the three types of immunocompromised patients in mind – the mild, the moderate and the severe, says infectious disease physician and virologist Professor Tony Cunningham.

Expert/s: Rosalyn Page

Infectious diseases

Vaccines build on herd immunity

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Preparing for the next COVID wave

GPs should plan antivirals for high- risk patients

Here’s another type of COVID test to get your head around. But is this new home kit worth the cost?

A new type of COVID test is set to be available from November for Australians to use at home.

Practical guide to using COVID antivirals in primary care

Navigating interactions... it’s easier than it first looks, and how antivirals are an important part of the management strategy to reduce the chances of severe illness and hospital admissions

The best COVID antivirals to prescribe

Under national guidelines, patients with COVID at high risk of serious illness should be prescribed nirmatrelvir (Paxlovid) by GPs, with the less effective molnupiravir (Lagevrio) a second-line option.

COVID Update, Vaccines, and Re-emerging Infections

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?

Campaign to encourage complacent Australians to get boosted

The Immunisation Coalition has launched a campaign called 'Take It From Me' to encourage Australians to get boosted.

Alarming time for infectious diseases

Vigilance is required now international travel is back, says Associate Professor Sanjaya Senanayake.

COVID Update, Monkeypox and other outbreaks to keep an eye on

Monkeypox, influenza, polio, tomato flu and other things that are keeping public health up at night, latest COVID developments, ATAGI announcements.

Australia needs a CDC: Nigel Crawford

It’s time to emerge from the ‘bubble of COVID’ and check out what other countries are doing to keep track of vaccination rates and impacts, says paediatrician Associate Professor Nigel Crawford.

Shingles vaccination in the immunocompromised – Which option for which patient?

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

What counts as ‘immunocompromised’ for Zostavax?

When deciding whether to administer Zostavax or not, it’s useful to keep the three types of immunocompromised patients in mind – the mild, the moderate and the severe, says infectious disease physician and virologist Professor Tony Cunningham.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Practical Strategies for Behaviour Management in Dementia

Tuesday 7th July, 7pm - 9pm AEST

Speaker

Dr Chrys Pulle

Geriatrician; Principal Investigator, Internal Medicine and Dementia Research Unit, The Prince Charles Hospital

Dr Chrys Pulle provides practical and evidence-based recommendations on how best these behavioural and psychological symptoms can be assessed and managed.

Infectious diseases

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

GPs should plan antivirals for high- risk patients

A new type of COVID test is set to be available from November for Australians to use at home.

Navigating interactions... it’s easier than it first looks, and how antivirals are an important part of the management strategy to reduce the chances of severe illness and hospital admissions

Under national guidelines, patients with COVID at high risk of serious illness should be prescribed nirmatrelvir (Paxlovid) by GPs, with the less effective molnupiravir (Lagevrio) a second-line option.

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?

The Immunisation Coalition has launched a campaign called 'Take It From Me' to encourage Australians to get boosted.

Vigilance is required now international travel is back, says Associate Professor Sanjaya Senanayake.

Monkeypox, influenza, polio, tomato flu and other things that are keeping public health up at night, latest COVID developments, ATAGI announcements.

It’s time to emerge from the ‘bubble of COVID’ and check out what other countries are doing to keep track of vaccination rates and impacts, says paediatrician Associate Professor Nigel Crawford.

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

When deciding whether to administer Zostavax or not, it’s useful to keep the three types of immunocompromised patients in mind – the mild, the moderate and the severe, says infectious disease physician and virologist Professor Tony Cunningham.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Practical Strategies for Behaviour Management in Dementia

Tuesday 7th July, 7pm - 9pm AEST

Speaker

Dr Chrys Pulle

Geriatrician; Principal Investigator, Internal Medicine and Dementia Research Unit, The Prince Charles Hospital

Dr Chrys Pulle provides practical and evidence-based recommendations on how best these behavioural and psychological symptoms can be assessed and managed.